Dirk Kersten - Aug 8, 2024 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Director
Signature
/s/ Dirk Kersten
Stock symbol
DYN
Transactions as of
Aug 8, 2024
Transactions value $
-$7,877,091
Form type
4
Date filed
8/12/2024, 04:05 PM
Previous filing
May 24, 2024
Next filing
Aug 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Sale -$260K -6.38K -0.1% $40.74 6.41M Aug 8, 2024 See footnote F1, F2, F3
transaction DYN Common Stock Sale -$703K -16.4K -0.26% $42.97 6.39M Aug 8, 2024 See footnote F1, F3, F4
transaction DYN Common Stock Sale -$2.96M -68.9K -1.08% $42.87 6.33M Aug 8, 2024 See footnote F1, F3, F5
transaction DYN Common Stock Sale -$2.16M -50.7K -0.8% $42.55 6.27M Aug 9, 2024 See footnote F1, F3, F6
transaction DYN Common Stock Sale -$1.75M -40.3K -0.64% $43.44 6.23M Aug 9, 2024 See footnote F1, F3, F7
transaction DYN Common Stock Sale -$51.1K -1.16K -0.02% $44.04 6.23M Aug 9, 2024 See footnote F1, F3, F8
holding DYN Common Stock 1.43M Aug 8, 2024 See footnote F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Forbion Capital Fund IV Cooperatief U.A. ("FCF IV") on April 9, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $40.60 to $41.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in the footnotes of this Form 4.
F3 The shares are held directly by FCF IV. Forbion IV Management B.V. ("Forbion Management"), the director of FCF IV, may be deemed to have voting and dispositive power over the shares held by FCF IV. Investment decisions with respect to the shares held by FCF IV can be made by FCPM III Services B.V., the director of Forbion Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of Forbion Management. Messrs. Slootweg, van Osch, Mulder, van Houten, Reithinger and Boorsma (the "Partners") are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FCF IV. The Reporting Person is a partner of Forbion Management and a member of the investment committee of Forbion Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $41.605 to $42.435, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $42.465 to $43.23, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $41.985 to $42.98, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $42.99 to $43.98, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $43.995 to $44.06, inclusive.
F9 The shares are held directly by Forbion Growth Opportunities Fund II Cooperatief U.A. ("FGO II"). Forbion Growth II Management B.V. ("FGO II Management"), the director of FGO II, may be deemed to have voting and dispositive power over the shares held by FGO II. Investment decisions with respect to the shares held by FGO II can be made by FCPM III Services B.V., the director of FGO II Management, which may delegate such powers to its investment committee which may delegate such powers to the authorized representatives of FGO II Management. The Partners are partners of FCPM III Services B.V., which acts as the investment advisor to the directors of FGO II. The Reporting Person is a partner of FGO II Management and a member of the investment committee of FGO II Management. The Reporting Person disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest therein.